Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Roche

Mentioned in 5 analyzed podcast episodes across 5 shows

Episode Mentions

Behind the Bastards

Behind the Bastards · Mar 3, 2026

Part One: Dr. Sleep: The Australian Psychiatrist Who Made People Sleep Themselves To Death

Pharmaceutical manufacturer whose barbiturates were exclusively used by early DST pioneer Jacob Kleisse in his treatment protocols

Deep Sleep Therapy (DST) - medical history and dangersPsychiatric treatment ethics and informed consent in mid-20th centuryFinancial incentive structures in healthcare and overtreatment
View Analysis
The a16z Show

The a16z Show · Feb 16, 2026

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

Novartis sold its stake in Roche as part of portfolio simplification strategy

Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology
View Analysis
This Week in Virology

This Week in Virology · Jan 31, 2026

TWiV 1292: Clinical update with Dr. Daniel Griffin

Manufacturer of Zofluza (baloxavir marboxil), single-dose influenza antiviral discussed as alternative to Tamiflu

WHO Withdrawal and Global Health GovernanceVaccine Hesitancy and Immunization PolicyMeasles Resurgence and Elimination Status
View Analysis
Something You Should Know

Something You Should Know · Jan 5, 2026

How Ozempic and Similar Weight Loss Drugs Really Work & The Story of Money

Swiss pharmaceutical company developing a GLP-1 drug franchise to compete in weight loss medication market

GLP-1 Receptor Agonists and Weight Loss MechanismsMental Imagery and Skill AcquisitionOzempic and Semaglutide Side Effects
View Analysis
Dwarkesh Podcast

Dwarkesh Podcast · Aug 21, 2025

Evolution designed us to die fast; we can change that — Jacob Kimmel

Pharma company with significant internal R&D in perturb-seq technology and cellular reprogramming led by Viola Gev

Evolutionary constraints on human lifespan and agingEpigenetic reprogramming and cell age reversalTranscription factors as therapeutic targets
View Analysis